86 results
Page 2 of 5
8-K
EX-99.2
d7uu6jdeeb
22 Jun 22
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
7:05am
8-K
EX-99.1
kq8jncieyunda kp
22 Jun 22
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
7:05am
8-K
EX-99.1
mzci2vaklv9i3sw6xi
12 May 22
Athira Pharma Reports First Quarter 2022 Financial Results
4:12pm
DEFA14A
t9etj7m2aez8w22yh
11 May 22
Additional proxy soliciting materials
4:49pm
DEFA14A
c4kb67wqa9
9 May 22
Additional proxy soliciting materials
4:32pm
DFAN14A
EX-99.1
m4gjw
5 May 22
Additional proxy materials by non-management
11:00am
DFAN14A
EX-99.1
v7epx4zua3iwqjuufx65
27 Apr 22
Additional proxy materials by non-management
2:39pm
DFAN14A
EX-99.1
z87xmh8zpnb
25 Apr 22
Additional proxy materials by non-management
3:31pm
DFAN14A
EX-99.3
y7z8944l wjcze3m
22 Apr 22
Additional proxy materials by non-management
10:07am
DEFA14A
wwuxpw bwy0q5
11 Apr 22
Additional proxy soliciting materials
4:36pm
DEFC14A
jinjtj
11 Apr 22
Proxy in contested solicitation
8:36am
PREC14A
0axlle j61dj2b34dwu
8 Apr 22
Preliminary proxy with contested solicitation
4:21pm
DEFC14A
hwj7kn
5 Apr 22
Proxy in contested solicitation
4:08pm
PREC14A
3eu9f9b02wb
30 Mar 22
Preliminary proxy with contested solicitation
5:23pm
DFAN14A
1sntif47tr8 jqg
30 Mar 22
Additional proxy materials by non-management
10:21am
PREC14A
61f 294p3ar
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
8-K
EX-99.1
pd0 giytx8s
24 Mar 22
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
4:11pm